{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:45:07Z","timestamp":1787899507294,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004061","name":"Oesterreichische Nationalbank","doi-asserted-by":"publisher","award":["17600"],"award-info":[{"award-number":["17600"]}],"id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bbadis.2023.166924","type":"journal-article","created":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T03:24:00Z","timestamp":1698463440000},"page":"166924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prostaglandin 15d-PGJ2 inhibits proliferation of lung adenocarcinoma cells by inducing ROS production and activation of apoptosis via sirtuin-1"],"prefix":"10.1016","volume":"1870","author":[{"given":"Julia","family":"Slanovc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateja","family":"Mikul\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6696-8717","authenticated-orcid":false,"given":"Nassim Ghaffari Tabrizi","family":"Wizsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9860-1063","authenticated-orcid":false,"given":"Wolfgang","family":"Sattler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Malle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8149-8191","authenticated-orcid":false,"given":"Andelko","family":"Hrzenjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2023.166924_bb0005","doi-asserted-by":"crossref","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10066","key":"10.1016\/j.bbadis.2023.166924_bb0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166924_bb0015","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s12035-017-0435-4","article-title":"Physiological and pathological roles of 15-deoxy-delta(12,14)-prostaglandin J2 in the central nervous system and neurological diseases","volume":"55","author":"Yagami","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166924_bb0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/tx700177j","article-title":"15-Deoxy-delta(12,14)-prostaglandin J2: an electrophilic trigger of cellular responses","volume":"21","author":"Uchida","year":"2008","journal-title":"Chem. Res. Toxicol."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166924_bb0025","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.freeradbiomed.2009.06.030","article-title":"Regulation of Nrf2-dependent gene expression by 15-deoxy-delta12,14-prostaglandin J2","volume":"47","author":"Kansanen","year":"2009","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166924_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030526","article-title":"15-Deoxy-delta(12,14)-prostaglandin J2 upregulates VEGF expression via NRF2 and heme oxygenase-1 in human breast cancer cells","volume":"10","author":"Kim","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166924_bb0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCRESAHA.118.313820","article-title":"15-Deoxy-delta12,14-prostaglandin J2 reinforces the anti-inflammatory capacity of endothelial cells with a genetically determined NO deficit","volume":"125","author":"Urban","year":"2019","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166924_bb0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbamcr.2004.10.016","article-title":"Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species","volume":"1743","author":"Chen","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166924_bb0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1210\/me.2012-1313","article-title":"Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells","volume":"27","author":"Kaikkonen","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbadis.2023.166924_bb0050","doi-asserted-by":"crossref","first-page":"4106297","DOI":"10.1155\/2016\/4106297","article-title":"15-Deoxy-delta(12,14)-prostaglandin J2 induces apoptosis and upregulates SOCS3 in human thyroid cancer cells","volume":"2016","author":"Trindade-da-Silva","year":"2016","journal-title":"PPAR Res."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166924_bb0055","first-page":"3223","article-title":"15d-PGJ2 induces apoptosis of MCF-7 and MDA-MB-231 cells via increased intracellular calcium and activation of caspases, independent of ERalpha and ERbeta","volume":"17","author":"Muhammad","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"17","key":"10.1016\/j.bbadis.2023.166924_bb0060","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1158\/1078-0432.CCR-08-3101","article-title":"15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity","volume":"15","author":"Shin","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2023.166924_bb0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bcp.2016.01.011","article-title":"Activation of the MAPK\/Akt\/Nrf2-Egr1\/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death","volume":"104","author":"Koyani","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"21","key":"10.1016\/j.bbadis.2023.166924_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111760","article-title":"15d-PGJ2 promotes ROS-dependent activation of MAPK-induced early apoptosis in osteosarcoma cell in vitro and in an ex ovo CAM assay","volume":"22","author":"Mikulcic","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166924_bb0075","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma","volume":"83","author":"Forman","year":"1995","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166924_bb0080","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell"},{"issue":"3\u20134","key":"10.1016\/j.bbadis.2023.166924_bb0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.prostaglandins.2011.01.004","article-title":"Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARgamma activation in non-small cell lung carcinoma A549 cells","volume":"94","author":"Wang","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166924_bb0090","first-page":"958","article-title":"Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells","volume":"63","author":"Qin","year":"2003","journal-title":"Cancer Res."},{"issue":"4391","key":"10.1016\/j.bbadis.2023.166924_bb0095","first-page":"46","article-title":"Synergistic antiproliferative effects of combined gamma -tocotrienol and PPAR gamma antagonist treatment are mediated through PPAR gamma -independent mechanisms in breast cancer cells","volume":"2014","author":"Malaviya","year":"2014","journal-title":"PPAR Res."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166924_bb0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11596-007-0207-x","article-title":"Peroxisome proliferator-activated receptor-gamma activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis","volume":"23","author":"Zhang","year":"2003","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"issue":"11","key":"10.1016\/j.bbadis.2023.166924_bb0105","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1042\/CBI20100707","article-title":"Induction of apoptosis in non-small cell lung carcinoma A549 cells by PGD(2) metabolite, 15d-PGJ(2)","volume":"35","author":"Wang","year":"2011","journal-title":"Cell Biol. Int."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166924_bb0110","first-page":"2518","article-title":"Novel SIRT1 inhibitor 15-deoxy-delta12,14-prostaglandin J2 and its derivatives exhibit anticancer activity through apoptotic or autophagic cell death pathways in SKOV3 cells","volume":"53","author":"Tae","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166924_bb0115","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3892\/ijo.2012.1534","article-title":"Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells","volume":"41","author":"Wang","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166924_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025192","article-title":"Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC","volume":"6","author":"de Jong","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbadis.2023.166924_bb0125","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00418-008-0536-2","article-title":"Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis","volume":"130","author":"Deryugina","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.bbadis.2023.166924_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers15010191","article-title":"The CAM model-Q&A with experts","volume":"15","author":"Fischer","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.bbadis.2023.166924_bb0135","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1172\/JCI19796","article-title":"15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product?","volume":"112","author":"Powell","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166924_bb0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bcp.2007.03.023","article-title":"PGD2 metabolism in plasma: kinetics and relationship with bioactivity on DP1 and CRTH2 receptors","volume":"74","author":"Schuligoi","year":"2007","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166924_bb0145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00216-017-0748-1","article-title":"Sensitive mass spectrometric assay for determination of 15-deoxy-delta(12,14)-prostaglandin J2 and its application in human plasma samples of patients with diabetes","volume":"410","author":"Morgenstern","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166924_bb0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/med.1006","article-title":"Cyclopentenone prostaglandins: new insights on biological activities and cellular targets","volume":"21","author":"Straus","year":"2001","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166924_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.10119","article-title":"Cellular response to oxidative stress: signaling for suicide and survival","volume":"192","author":"Martindale","year":"2002","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166924_bb0160","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4161\/cbt.8.7.7853","article-title":"Peroxisome proliferator-activated receptor gamma in bladder cancer: a promising therapeutic target","volume":"8","author":"Mansure","year":"2009","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166924_bb0165","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s12253-012-9517-9","article-title":"Expression of peroxisome proliferator activated receptor-gamma (PPAR-gamma) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients\u2019 survival","volume":"18","author":"Giaginis","year":"2012","journal-title":"Pathol. Oncol. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166924_bb0170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc1254","article-title":"Peroxisome-proliferator-activated receptors and cancers: complex stories","volume":"4","author":"Michalik","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2023.166924_bb0175","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/134059","article-title":"PPARs mediate lipid signaling in inflammation and cancer","volume":"2008","author":"Michalik","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.bbadis.2023.166924_bb0180","doi-asserted-by":"crossref","first-page":"8972570","DOI":"10.1155\/2016\/8972570","article-title":"PPARgamma as a novel therapeutic target in lung cancer","volume":"2016","author":"Reddy","year":"2016","journal-title":"PPAR Res."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166924_bb0185","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-5002(02)00013-2","article-title":"Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinoma: correlation with histological type and grade","volume":"36","author":"Theocharis","year":"2002","journal-title":"Lung Cancer"},{"issue":"52","key":"10.1016\/j.bbadis.2023.166924_bb0190","doi-asserted-by":"crossref","first-page":"20979","DOI":"10.1073\/pnas.0707394104","article-title":"Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2","volume":"104","author":"Rajakariar","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166924_bb0195","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijcard.2014.03.086","article-title":"15-Deoxy-delta(1)(2),(1)(4)-PGJ(2) promotes inflammation and apoptosis in cardio- myocytes via the DP2\/MAPK\/TNFalpha axis","volume":"173","author":"Koyani","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.bbadis.2023.166924_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081879","article-title":"Role of NRF2 in lung cancer","volume":"10","author":"Sanchez-Ortega","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.bbadis.2023.166924_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111755","article-title":"The role of Nrf2 activity in cancer development and progression","volume":"11","author":"Zimta","year":"2019","journal-title":"Cancers"},{"issue":"13","key":"10.1016\/j.bbadis.2023.166924_bb0210","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1089\/ars.2020.8024","article-title":"Nuclear factor erythroid 2-related factor 2 in regulating cancer metabolism","volume":"33","author":"Smolkova","year":"2020","journal-title":"Antioxid. Redox Signal."},{"issue":"20","key":"10.1016\/j.bbadis.2023.166924_bb0215","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1101\/gad.225680.113","article-title":"The emerging role of the Nrf2-Keap1 signaling pathway in cancer","volume":"27","author":"Jaramillo","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2023.166924_bb0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2019.09.016","article-title":"\u201cNRF2 addiction\u201d in lung cancer cells and its impact on cancer therapy","volume":"467","author":"Hammad","year":"2019","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166924_bb0225","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3892\/ol.2014.2057","article-title":"Sirt1 is a tumor promoter in lung adenocarcinoma","volume":"8","author":"Chen","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbadis.2023.166924_bb0230","first-page":"1399","article-title":"The emerging and diverse roles of sirtuins in cancer: a clinical perspective","volume":"6","author":"Yuan","year":"2013","journal-title":"OncoTargets Ther."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2023.166924_bb0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1615\/CritRevOncog.2014012374","article-title":"Multifaceted modulation of SIRT1 in cancer and inflammation","volume":"20","author":"Yang","year":"2015","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.bbadis.2023.166924_bb0240","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2147\/OTT.S82378","article-title":"SIRT1 expression is associated with poor prognosis of lung adenocarcinoma","volume":"8","author":"Li","year":"2015","journal-title":"OncoTargets Ther."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166924_bb0245","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41419-019-1592-3","article-title":"SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer","volume":"10","author":"Yousafzai","year":"2019","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166924_bb0250","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1074\/jbc.M110.208173","article-title":"Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization","volume":"286","author":"Kawai","year":"2011","journal-title":"J. Biol. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923002909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923002909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T05:16:04Z","timestamp":1735708564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443923002909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0925443923002909"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166924","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostaglandin 15d-PGJ2 inhibits proliferation of lung adenocarcinoma cells by inducing ROS production and activation of apoptosis via sirtuin-1","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166924"}}